内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Cogent Biosciences, Inc.

COGT · Nasdaq · CIK 0001622229 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

5 同一窗口内观察到的 Form 4 交易行
2 sales · 3 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-07-10 · Fairmount Funds Management LLC · $25.0M

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出较低
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Morris ArleneDirector
○▼
Robbins Andrew RPresident and CEO
○
● 买入▼ 卖出○ 其他

—

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-07-10 · Fairmount Funds Management LLC.

近期 Form 4 活动

0买入
8卖出
22其他 Form 4 交易行
14SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他3 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
19,462,718
上期报告
18,126,492
日均成交量
2,410,217
回补天数
8.1

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-07-10Fairmount Funds Management LLC买入 (P)Common Stock2,777,777USD 9.00USD 24,999,993SEC 申报 ↗
2025-01-14Pinnow Cole买入 (P)Common Stock43,750USD 7.60USD 332,500SEC 申报 ↗
2023-06-09Fairmount Funds Management LLC买入 (P)Common Stock800,000USD 12.00USD 9,600,000SEC 申报 ↗
2022-06-16Fairmount Funds Management LLC买入 (P)Common Stock1,200,000USD 8.25USD 9,900,000SEC 申报 ↗
2020-08-18Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings II, LLC; VHCP Co-Investment Holdings III, LLC; VHCP Management II, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners II, L.P.; Venrock Healthcare Capital Partners III, L.P.买入 (P)Common Stock101,000USD 2.62USD 264,620SEC 申报 ↗
2020-08-17Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings II, LLC; VHCP Co-Investment Holdings III, LLC; VHCP Management II, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners II, L.P.; Venrock Healthcare Capital Partners III, L.P.买入 (P)Common Stock250,000USD 2.57USD 642,500SEC 申报 ↗
2020-08-14Koh Bong Y; Shah Nimish P; VHCP Co-Investment Holdings II, LLC; VHCP Co-Investment Holdings III, LLC; VHCP Management II, LLC; VHCP Management III, LLC; Venrock Healthcare Capital Partners II, L.P.; Venrock Healthcare Capital Partners III, L.P.买入 (P)Common Stock100,000USD 2.30USD 230,000SEC 申报 ↗

Form 4 申报证据

30 transaction lines in the latest 365-day window; 72 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-27Morris Arlene卖出 (S)Common Stock45,510USD 37.12USD 1,689,388SEC 申报 ↗
2026-08-27Morris Arlene期权行权／转换 (M)Common Stock45,510USD 5.39USD 245,497SEC 申报 ↗
2026-05-19Robbins Andrew R赠与 (G)Common Stock160,000USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (22 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-27Morris Arlene卖出 (S)Common Stock45,510USD 37.12USD 1,689,388SEC 申报 ↗
2026-08-27Morris Arlene期权行权／转换 (M)Common Stock45,510USD 5.39USD 245,497SEC 申报 ↗
2026-05-19Robbins Andrew R赠与 (G)Common Stock160,000USD 0.00USD 0SEC 申报 ↗
2026-03-31Fairmount Funds Management LLC卖出 (S)Common Stock7,000,000USD 34.66USD 242,620,000SEC 申报 ↗
2026-03-31Fairmount Funds Management LLCC (C)Common Stock7,000,000USD —USD —SEC 申报 ↗
2026-01-22Fairmount Funds Management LLC卖出 (S)Common Stock3,500,000USD 36.40USD 127,400,000SEC 申报 ↗
2025-12-26Sachs Jessica卖出 (S)Common Stock82,642USD 38.70USD 3,198,245SEC 申报 ↗
2025-12-26Robinson John Edward卖出 (S)Common Stock90,000USD 38.74USD 3,486,600SEC 申报 ↗
2025-12-26Kearns Evan卖出 (S)Common Stock65,000USD 38.70USD 2,515,500SEC 申报 ↗
2025-12-26Green John L.卖出 (S)Common Stock77,000USD 38.68USD 2,978,360SEC 申报 ↗
2025-12-17Sachs Jessica代扣税 (F)Common Stock154,716USD 39.45USD 6,103,546SEC 申报 ↗
2025-12-17Sachs Jessica奖励／授予 (A)Common Stock370,000USD 0.00USD 0SEC 申报 ↗
2025-12-17Robinson John Edward代扣税 (F)Common Stock139,998USD 39.45USD 5,522,921SEC 申报 ↗
2025-12-17Robinson John Edward奖励／授予 (A)Common Stock370,000USD 0.00USD 0SEC 申报 ↗
2025-12-17Robbins Andrew R代扣税 (F)Common Stock367,497USD 39.45USD 14,497,757SEC 申报 ↗
2025-12-17Robbins Andrew R奖励／授予 (A)Common Stock1,025,000USD 0.00USD 0SEC 申报 ↗
2025-12-17Pinnow Cole代扣税 (F)Common Stock94,800USD 39.45USD 3,739,860SEC 申报 ↗
2025-12-17Pinnow Cole奖励／授予 (A)Common Stock264,000USD 0.00USD 0SEC 申报 ↗
2025-12-17Kearns Evan代扣税 (F)Common Stock125,602USD 39.45USD 4,954,999SEC 申报 ↗
2025-12-17Kearns Evan奖励／授予 (A)Common Stock300,000USD 0.00USD 0SEC 申报 ↗
2025-12-17Green John L.代扣税 (F)Common Stock145,007USD 39.45USD 5,720,526SEC 申报 ↗
2025-12-17Green John L.奖励／授予 (A)Common Stock350,000USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码COGT
CIK0001622229
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史72 transaction lines from 2020-04-06 to 2026-08-27
7 P purchase lines · 32 S sale lines · 33 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.